Sort
326,823 grants matching “clinical trial”
1/2 PROSpect: Prone and Oscillation Pediatric Clinical Trial (CCC)
$1,765,538Martha Aq Curley · University Of Pennsylvania · UH3 · FY2020 · HL
ACISR for Late-Life Depression Prevention
$1,765,451Charles F Reynolds · University Of Pittsburgh At Pittsburgh · P30 · FY2011 · MH
Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis
$1,765,337Geoffrey I Shapiro · Dana-Farber Cancer Inst · UM1 · FY2016 · CA
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
$1,765,234Fernando D Martinez · University Of Arizona · UH3 · FY2022 · HL
EPVent 2-A Phase II Trial Esophageal Pressure Guided Ventilation
$1,765,182Daniel Stuart Talmor · Beth Israel Deaconess Medical Center · UM1 · FY2013 · HL
Male Circumcision Trial for HIV Prevention, Rakai-Uganda
$1,765,169Johns Hopkins University · U01 · FY2004 · AI
Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with LEOPARD Syndrome
$1,765,116Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
DEX-M74 for GNE Myopathy
$1,765,116Na Yang · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Inhaled GM-CSF Therapy of Autoimmune Pulmonary Alveolar Proteinosis
$1,765,116Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Long-Acting Parathyroid Hormone Analog for the Treatment of Hypoparathyroidism
$1,765,116Na Yang · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
A Novel Compound for Targeted Treatment of CBF Leukemia
$1,765,116Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Cyclodextrin for Niemann-Pick Type C1 Disease
$1,765,116Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
LUM-001 as a Treatment for Creatine Transporter Deficiency
$1,765,116Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE
$1,764,494University Of Colorado Denver · U01 · FY2002 · HL
Safety and Pharmacokinetics of JOTROL for Alzheimer's Disease
$1,764,270Marshall Hayward · Jupiter Neurosciences, Inc. · R44 · FY2020 · AG
Effectiveness of Relationship Education for Reducing HIV Incidence in Men Who Have Sex with Men
$1,764,157Michael E Newcomb · Northwestern University At Chicago · U01 · FY2021 · AI
SOFT TISSUE SARCOMA PROGRAM PROJECT
$1,764,115Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA
University of Cape Town Clinical Trials Unit (UCTCTU)
$1,764,076Linda-Gail Bekker · University Of Cape Town · UM1 · FY2018 · AI
NK cells, their receptors and cancer therapy
$1,764,019Jeffrey S Miller · University Of Minnesota · P01 · FY2021 · CA
Chronic HIV infection and Aging in NeuroAIDS (CHAIN) Center
$1,763,985Howard S. Fox · University Of Nebraska Medical Center · P30 · FY2012 · MH
REGULATION OF ANGIOGENESIS
$1,763,726Children'S Hospital Boston · P01 · FY2001 · CA
Immunotherapy with High Frequency, CEA Specific T Cells
$1,763,593Duke University · P01 · FY2005 · CA
Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) - DCC
$1,763,568Christopher S. Coffey · University Of Iowa · U01 · FY2022 · NS
Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) - DCC
$1,763,568Christopher S. Coffey · University Of Iowa · U01 · FY2019 · NS
Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) - DCC
$1,763,568Christopher S. Coffey · University Of Iowa · U01 · FY2021 · NS